These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10190722)

  • 1. Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group.
    Poupon R; Chazouillères O; Balkau B; Poupon RE
    J Hepatol; 1999 Mar; 30(3):408-12. PubMed ID: 10190722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression.
    Degott C; Zafrani ES; Callard P; Balkau B; Poupon RE; Poupon R
    Hepatology; 1999 Apr; 29(4):1007-12. PubMed ID: 10094939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis.
    Corpechot C; Poujol-Robert A; Wendum D; Galotte M; Chrétien Y; Poupon RE; Poupon R
    Liver Int; 2004 Jun; 24(3):187-93. PubMed ID: 15189267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy.
    Chazouillères O; Wendum D; Serfaty L; Montembault S; Rosmorduc O; Poupon R
    Hepatology; 1998 Aug; 28(2):296-301. PubMed ID: 9695990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and pathological characteristics of primary biliary cirrhosis].
    Wang J; Jiang W; Gao H; He B; Liu W
    Zhonghua Gan Zang Bing Za Zhi; 2002 Oct; 10(5):334-7. PubMed ID: 12392609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune overlapping syndromes.
    Poupon R
    Clin Liver Dis; 2003 Nov; 7(4):865-78. PubMed ID: 14594134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Balkau B; Eschwège E; Poupon R
    N Engl J Med; 1991 May; 324(22):1548-54. PubMed ID: 1674105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.
    Poupon RE; Eschwège E; Poupon R
    J Hepatol; 1990 Jul; 11(1):16-21. PubMed ID: 1975819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis.
    Combes B; Markin RS; Wheeler DE; Rubin R; West AB; Mills AS; Eigenbrodt EH; Maddrey WC; Munoz SJ; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White HM; Zetterman RK; Carithers RL
    Hepatology; 1999 Sep; 30(3):602-5. PubMed ID: 10462363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid.
    Vuoristo M; Färkkilä M; Karvonen AL; Leino R; Lehtola J; Mäkinen J; Mattila J; Friman C; Seppälä K; Tuominen J
    Gastroenterology; 1995 May; 108(5):1470-8. PubMed ID: 7729640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Florid duct lesion in primary biliary cirrhosis shows highly proliferative activities.
    Nakanuma Y; Harada K
    J Hepatol; 1993 Sep; 19(2):216-21. PubMed ID: 7905494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis.
    Batts KP; Jorgensen RA; Dickson ER; Lindor KD
    Am J Gastroenterol; 1996 Nov; 91(11):2314-7. PubMed ID: 8931409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
    Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
    J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canals of Hering loss relates to the progression of the histological stages of primary biliary cirrhosis.
    Kakuda Y; Harada K; Nakanuma Y
    J Clin Pathol; 2015 Feb; 68(2):141-7. PubMed ID: 25430494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histopathological features of 27 cases of primary biliary cirrhosis].
    Shi X; Zhang C; Jia J; Zhang F; Qian L; Wang B
    Zhonghua Gan Zang Bing Za Zhi; 2002 Oct; 10(5):338-40. PubMed ID: 12392610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.
    Lindor KD; Dickson ER; Baldus WP; Jorgensen RA; Ludwig J; Murtaugh PA; Harrison JM; Wiesner RH; Anderson ML; Lange SM
    Gastroenterology; 1994 May; 106(5):1284-90. PubMed ID: 8174890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary biliary cirrhosis: safety and benefits of established and emerging therapies.
    Tabibian JH; Lindor KD
    Expert Opin Drug Saf; 2015; 14(9):1435-44. PubMed ID: 26212223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.